MG
Meditor Group Portfolio holdings
AUM
$48.1M
This Quarter Return
+11.11%
1 Year Return
+38.67%
3 Year Return
+41.15%
5 Year Return
+72.2%
10 Year Return
+1,065.64%
AUM
$356M
AUM Growth
+$356M
(-0.94%)
Cap. Flow
-$42.2M
Cap. Flow
% of AUM
-11.85%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
1
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Exelixis
EXEL
|
$30.2M |
| 2 |
Alkermes
ALKS
|
$12M |
Sector Composition
| 1 | Healthcare | 92.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Exelixis
EXEL
$10.1B
| $255M | 71.55% | 11,275,871 -1,334,669 | -11% | -$30.2M |
|
2
Esperion Therapeutics
ESPR
$448M
| $75.2M | 21.12% | 2,679,835 | – | – |
|
3
iShares MSCI India ETF
INDA
$9.17B
| $13.5M | 3.79% | 320,000 | – | – |
|
4
WisdomTree India Earnings Fund ETF
EPI
$2.86B
| $12.6M | 3.54% | 400,000 | – | – |
|
|
5
Alkermes
ALKS
$4.78B
| – | – | -603,790 | Closed | -$12M |
|